News
BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market
BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing ...
Pep Talk January 2026
In our first newsletter of 2026 we share exciting news for our cell therapy grade and new application notes, technotes ...
Qkine Limited and Akron Bio Announce Strategic Partnership
Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics ...
Pricing update January 2026
Keeping you updated with our last shipping dates for 2025 and the first shipping dates of 2026 ...
Pep Talk December 2025
In our December newsletter we discuss the pitfalls with commercial media, also find our newest application notes, events and publications ...
Last shipping dates of 2025 & first shipping dates of 2026
Keeping you updated with our last shipping dates for 2025 and the first shipping dates of 2026 ...
Pep Talk November 2025
In our November newsletter we share the journey to a highly potent IL-34 and discuss the pitfalls with commercial media, ...
Commercially available media – the hidden pitfalls of proprietary formulations
Commercial media preparations can be a convenient option for stem cell and organoid maintenance and differentiation, but the proprietary 'black ...






